jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Feb. 01, 2023

July. 24, 2025

jRCT2033220602

Continuous observation study after administration of ADR-001 in patients with Compensated Liver Cirrhosis

ADR-001-N2

Terai Shuji

Niigata University Medical and Dental Hospital

754, Ichibancho, Asahimachidori, Chuo-ku, Niigata-shi, Niigata

+81-25-227-2207

terais@med.niigata-u.ac.jp

Watanabe Yusuke

Niigata University Medical and Dental Hospital

754, Ichibancho, Asahimachidori, Chuo-ku, Niigata-shi, Niigata

+81-25-227-2207

ywatanabe19840421@med.niigata-u.ac.jp

Complete

Jan. 30, 2023

Feb. 14, 2023
9

Observational

1)Patients who received at least one dose of ADR-001 in the ADR-001-N1 Study.
2)Patients capable of giving written informed consent.

1)Patients decided to be ineligible for this study by the investigator.

20age old over
No limit

Both

Compensated liver cirrhosis (Child-Pugh A)

The amount of change in Albumin-bilirubin (ALBI) score

ROHTO Pharmaceutical Co., Ltd.
Not applicable
Niigata University Medical and Dental Hospital IRB
754,Ichibancho,Asahimachidori,Chuo-ku,Niigata-shi., Niigata

+81-25-227-0901

jimukyoku_ctrc@nuh.niigata-u.ac.jp
Approval

Dec. 27, 2022

No

none

History of Changes

No Publication date
4 July. 24, 2025 (this page) Changes
3 July. 01, 2023 Detail Changes
2 Feb. 23, 2023 Detail Changes
1 Feb. 01, 2023 Detail